|
2019 Journal Article Factors in randomized controlled trials reported to impact the implementation of patient-reported outcome measures into routine care: protocol for a systematic reviewRoberts, Natasha Anne, Alexander, Kimberly, Wyld, David and Janda, Monika (2019). Factors in randomized controlled trials reported to impact the implementation of patient-reported outcome measures into routine care: protocol for a systematic review. JMIR Research Protocols, 8 (11) e14579, e14579. doi: 10.2196/14579 |
|
2019 Journal Article What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi-disciplinary teamRoberts, Natasha A, Alexander, Kim, Wyld, David and Janda, Monika (2019). What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi-disciplinary team. European Journal of Cancer Care, 28 (6) e13167, e13167. doi: 10.1111/ecc.13167 |
|
2019 Journal Article The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient settingRoberts, Natasha Anne, Mudge, Alison, Alexander, Kim, Wyld, David and Janda, Monika (2019). The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting. BMJ Open, 9 (2) e027046, e027046. doi: 10.1136/bmjopen-2018-027046 |
|
2018 Journal Article Trials with proxy-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)Mercieca-Bebber, Rebecca, Williams, Douglas, Tait, Margaret-Ann, Rutherford, Claudia, Busija, Lucy, Roberts, Natasha, Wilson, Michelle, Shunmuga Sundaram, Chindhu and Roydhouse, Jessica (2018). Trials with proxy-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). Quality of Life Research, 28 (4), 955-962. doi: 10.1007/s11136-018-2080-4 |
|
2018 Journal Article Correction to: Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR) (Quality of Life Research, (2018), 27, 10, (2581-2591), 10.1007/s11136-018-1921-5)Mercieca-Bebber, Rebecca, Williams, Douglas, Tait, Margaret-Ann, Roydhouse, Jessica, Busija, Lucy, Sundaram, Chindhu Shunmuga, Wilson, Michelle, Langford, Ailsa, Rutherford, Claudia, Roberts, Natasha, King, Madeleine, Vodicka, Elisabeth and Devine, Beth (2018). Correction to: Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR) (Quality of Life Research, (2018), 27, 10, (2581-2591), 10.1007/s11136-018-1921-5). Quality of Life Research, 27 (10), 2593-2593. doi: 10.1007/s11136-018-1934-0 |
|
2018 Journal Article Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR)Mercieca-Bebber, Rebecca, Williams, Douglas, Tait, Margaret-Ann, Roydhouse, Jessica, Busija, Lucy, Sundaram, Chindhu Shunmuga, Wilson, Michelle, Langford, Ailsa, Rutherford, Claudia, Roberts, Natasha, King, Madeleine, Vodicka, Elisabeth, Devine, Beth and on behalf of the International Society for Quality of Life Research (ISOQOL) (2018). Trials with patient-reported outcomes registered on the Australian New Zealand Clinical Trials Registry (ANZCTR). Quality of Life Research, 27 (10), 2581-2591. doi: 10.1007/s11136-018-1921-5 |
|
2014 Journal Article Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltrationRoberts, Jason A., Udy, Andrew A., Bulitta, Juergen B., Stuart, Janin, Jarrett, Paul, Starr, Therese, Lassig-Smith, Melissa, Roberts, Natasha A., Dunlop, Rachel, Hayashi, Yoshiro, Wallis, Steven C. and Lipman, Jeffrey (2014). Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration. Journal of Antimicrobial Chemotherapy, 69 (9) dku177, 2508-2516. doi: 10.1093/jac/dku177 |
